• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Health Sciences Campus
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    •   ScholarShip Home
    • Health Sciences Campus
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy

    Thumbnail
    View/ Open
    oncotarget-02-538.PMC3248182.pdf (621.1Kb)

    Show full item record
    Author
    Sokolosky, Melissa L.; Stadelman, Kristin M.; Chappell, William H.; Abrams, Stephen L.; Martelli, Alberto M.; Stivala, Franca; Libra, Massimo; Nicoletti, Ferdinando; Drobot, Lyudmyla B.; Franklin, Richard A.; Steelman, Linda S.; McCubrey, James A.
    Abstract
    Elucidating the response of breast cancer cells to chemotherapeutic and hormonal based drugs is clearly important as these are frequently used therapeutic approaches. A signaling pathway often involved in chemo- and hormonal-resistance is the Ras/PI3K/PTEN/Akt/mTOR cascade. In the studies presented in this report, we have examined the effects of constitutive activation of Akt on the sensitivity of MCF-7 breast cancer cells to chemotherapeutic- and hormonal-based drugs as well as mTOR inhibitors. MCF-7 cells which expressed a constitutively-activated Akt-1 gene [ΔAkt-1(CA)] were more resistant to doxorubicin, etoposide and 4-OH-tamoxifen (4HT) than cells lacking ΔAkt-1(CA). Cells which expressed ΔAkt-1(CA) were hypersensitive to the mTOR inhibitor rapamycin. Furthermore, rapamycin lowered the IC50s for doxorubicin, etoposide and 4HT in the cells which expressed ΔAkt-1(CA), demonstrating a potential improved method for treating certain breast cancers which have deregulated PI3K/PTEN/Akt/mTOR signaling. Understanding how breast cancers respond to chemo- and hormonal-based therapies and the mechanisms by which they can become drug resistant may enhance our ability to treat breast cancer. These results also document the potential importance of knowledge of the mutations present in certain cancers which may permit more effective therapies.
    URI
    http://hdl.handle.net/10342/5703
    Subject
     Akt; mTOR; Targeted Therapy; Drug Resistance 
    Date
    2011-07
    Citation:
    APA:
    Sokolosky, Melissa L., & Stadelman, Kristin M., & Chappell, William H., & Abrams, Stephen L., & Martelli, Alberto M., & Stivala, Franca, & Libra, Massimo, & Nicoletti, Ferdinando, & Drobot, Lyudmyla B., & Franklin, Richard A., & Steelman, Linda S., & McCubrey, James A.. (July 2011). Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy. Oncotarget, 2(7), 538- 550. Retrieved from http://hdl.handle.net/10342/5703

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Sokolosky, Melissa L., and Stadelman, Kristin M., and Chappell, William H., and Abrams, Stephen L., and Martelli, Alberto M., and Stivala, Franca, and Libra, Massimo, and Nicoletti, Ferdinando, and Drobot, Lyudmyla B., and Franklin, Richard A., and Steelman, Linda S., and McCubrey, James A.. "Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy". Oncotarget. 2:7. (538-550), July 2011. September 27, 2023. http://hdl.handle.net/10342/5703.
    Chicago:
    Sokolosky, Melissa L. and Stadelman, Kristin M. and Chappell, William H. and Abrams, Stephen L. and Martelli, Alberto M. and Stivala, Franca and Libra, Massimo and Nicoletti, Ferdinando and Drobot, Lyudmyla B. and Franklin, Richard A. and Steelman, Linda S. and McCubrey, James A., "Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy," Oncotarget 2, no. 7 (July 2011), http://hdl.handle.net/10342/5703 (accessed September 27, 2023).
    AMA:
    Sokolosky, Melissa L., Stadelman, Kristin M., Chappell, William H., Abrams, Stephen L., Martelli, Alberto M., Stivala, Franca, Libra, Massimo, Nicoletti, Ferdinando, Drobot, Lyudmyla B., Franklin, Richard A., Steelman, Linda S., McCubrey, James A.. Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy. Oncotarget. July 2011; 2(7): 538-550. http://hdl.handle.net/10342/5703. Accessed September 27, 2023.
    Collections
    • Microbiology and Immunology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback